Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Plant Derivative Celastrol Prompts Cancer Cells to Self-Destruct

By LabMedica International staff writers
Posted on 16 Feb 2010
Celastrol, an anti-inflammatory plant derivative long used in Chinese medicine, has been found to have potential as an anticancer drug due to its ability to inhibit the procancer protein p23.

Investigators at the Medical College of Georgia (Augusta, USA) were studying the effect of celastrol on the heat shock protein HSP90, a key modulator of the inflammatory response and linked to both autoimmune diseases and cancer.

They reported in the February 5, 2010, issue of the Journal of Biological Chemistry that celastrol inhibited the Hsp90 chaperoning machinery by inactivating the cochaperone p23, resulting in selective destabilization of steroid receptors. More...
In vitro and in vivo results demonstrated that celastrol disrupted p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils.

"The celastrol induces the protein to form fibrils and clusters it together, which inactivates it,” explained senior author Dr. Ahmed Chadli, professor of biochemistry at the Medical College of Georgia. "When they are clustered, they are not available for other functions that help cancer grow."

"Cancer cells need HSP90 more than normal cells because cancer cells have thousands of mutations,” said Dr. Chadli. "They need chaperones all the time to keep their mutated proteins active. By taking heat shock proteins away from cells, the stabilization is taken away and cell death occurs.”

Related Links:
Medical College of Georgia



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sample Transportation System
Tempus1800 Necto
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.